Loading...
Requip, Requip XL
Antiparkinson • Dopamine agonist (D2/D3 preferring)
Directly stimulates D2/D3 dopamine receptors
Drug Class
Antiparkinson
Subclass
Dopamine agonist (D2/D3 preferring)
Half-life
6 hours
Time for plasma concentration to decrease by 50%
Protein Binding
40%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses